Andembry (garadacimab)

pCPA File Number: 23306
Negotiation Status:
Active Negotiation
Indication(s):
Hereditary Angioedema
Sponsor/Manufacturer:
CSL Behring Canada Inc.
CDA-AMC Project Number:
SR0860-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable